US 12331334
Modified urokinase-type plasminogen activator polypeptides and methods of use
granted A61KA61K31/727A61K38/00
Quick answer
US patent 12331334 (Modified urokinase-type plasminogen activator polypeptides and methods of use) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 65
- CPC classes
- A61K, A61K31/727, A61K38/00, A61K38/49, A61K45/06